These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 27626684

  • 1. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.
    Moench R, Grimmig T, Kannen V, Tripathi S, Faber M, Moll EM, Chandraker A, Lissner R, Germer CT, Waaga-Gasser AM, Gasser M.
    Oncotarget; 2016 Oct 18; 7(42):68749-68767. PubMed ID: 27626684
    [Abstract] [Full Text] [Related]

  • 2. PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway.
    Xiao Y, Peng H, Hong C, Chen Z, Deng X, Wang A, Yang F, Yang L, Chen C, Qin X.
    Cell Physiol Biochem; 2017 Oct 18; 42(4):1603-1613. PubMed ID: 28738389
    [Abstract] [Full Text] [Related]

  • 3. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
    Smit DJ, Cayrefourcq L, Haider MT, Hinz N, Pantel K, Alix-Panabières C, Jücker M.
    Cells; 2020 Sep 20; 9(9):. PubMed ID: 32962206
    [Abstract] [Full Text] [Related]

  • 4. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK, Wang ZL, Pan ST, Ding HQ, Au GH, He ZX, Zhou ZW, Xiao G, Yang YX, Zhang X, Yang T, Chen XW, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Sep 20; 9():1555-84. PubMed ID: 25792811
    [Abstract] [Full Text] [Related]

  • 5. Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway.
    Zhu Y, Zhong Y, Long X, Zhu Z, Zhou Y, Ye H, Zeng X, Zheng X.
    Pharm Biol; 2019 Dec 20; 57(1):412-423. PubMed ID: 31230505
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.
    Martinelli E, Troiani T, D'Aiuto E, Morgillo F, Vitagliano D, Capasso A, Costantino S, Ciuffreda LP, Merolla F, Vecchione L, De Vriendt V, Tejpar S, Nappi A, Sforza V, Martini G, Berrino L, De Palma R, Ciardiello F.
    Int J Cancer; 2013 Nov 20; 133(9):2089-101. PubMed ID: 23629727
    [Abstract] [Full Text] [Related]

  • 7. Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer.
    Moench R, Gasser M, Nawalaniec K, Grimmig T, Ajay AK, de Souza LCR, Cao M, Luo Y, Hoegger P, Ribas CM, Ribas-Filho JM, Malafaia O, Lissner R, Hsiao LL, Waaga-Gasser AM.
    Oncotarget; 2022 Oct 19; 13():1140-1152. PubMed ID: 36264073
    [Abstract] [Full Text] [Related]

  • 8. Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.
    Kumar S, Agnihotri N.
    Biomed Pharmacother; 2019 Jan 19; 109():1462-1477. PubMed ID: 30551398
    [Abstract] [Full Text] [Related]

  • 9. Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells.
    Yao W, Lin Z, Shi P, Chen B, Wang G, Huang J, Sui Y, Liu Q, Li S, Lin X, Liu Q, Yao H.
    Biochem Pharmacol; 2020 Jan 19; 171():113680. PubMed ID: 31669234
    [Abstract] [Full Text] [Related]

  • 10. Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells.
    Li X, Tian R, Liu L, Wang L, He D, Cao K, Ma JK, Huang C.
    J Int Med Res; 2020 Aug 19; 48(8):300060520946169. PubMed ID: 32787737
    [Abstract] [Full Text] [Related]

  • 11. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer.
    Grimmig T, Moench R, Kreckel J, Haack S, Rueckert F, Rehder R, Tripathi S, Ribas C, Chandraker A, Germer CT, Gasser M, Waaga-Gasser AM.
    Int J Mol Sci; 2016 Dec 08; 17(12):. PubMed ID: 27941651
    [Abstract] [Full Text] [Related]

  • 12. PI3K pathway is involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cells.
    Alonso N, Diaz Nebreda A, Monczor F, Gutkind JS, Davio C, Fernandez N, Shayo C.
    Biochim Biophys Acta; 2016 Sep 08; 1860(9):1998-2007. PubMed ID: 27316323
    [Abstract] [Full Text] [Related]

  • 13. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y, Li L, Huang M, Duan C, Zhang L, Chen J.
    Cell Signal; 2014 Dec 08; 26(12):2782-92. PubMed ID: 25193113
    [Abstract] [Full Text] [Related]

  • 14. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
    Pan ST, Qin Y, Zhou ZW, He ZX, Zhang X, Yang T, Yang YX, Wang D, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Dec 08; 9():1601-26. PubMed ID: 25834400
    [Abstract] [Full Text] [Related]

  • 15. Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways.
    Zhang L, Huo X, Liao Y, Yang F, Gao L, Cao L.
    Sci Rep; 2017 May 10; 7(1):1669. PubMed ID: 28490807
    [Abstract] [Full Text] [Related]

  • 16. Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII.
    Campbell M, Trimble ER.
    Circ Res; 2005 Feb 04; 96(2):197-206. PubMed ID: 15591231
    [Abstract] [Full Text] [Related]

  • 17. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
    Li Q, Tang H, Hu F, Qin C.
    J Cell Biochem; 2019 Mar 04; 120(3):3853-3860. PubMed ID: 30321450
    [Abstract] [Full Text] [Related]

  • 18. Rhodiolin inhibits the PI3K/AKT/mTOR signaling pathway via the glycolytic enzyme GPI in human papillary thyroid cancer.
    Bo J, Mao S, Yang J, Wang L, Zheng J, Zhang C, Song M, Chen S, Liu C.
    Phytomedicine; 2024 Sep 04; 132():155804. PubMed ID: 38943696
    [Abstract] [Full Text] [Related]

  • 19. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K, Huang W, Sang X, Wu X, Shan Q, Tang D, Xu X, Cao G.
    Phytomedicine; 2020 Mar 04; 68():153191. PubMed ID: 32135457
    [Abstract] [Full Text] [Related]

  • 20. [Inhibition effect of active fraction from clove on PI3K/Akt/mTOR signaling pathway to induce apoptosis of human colon cancer HCT116 cells].
    Zhao G, Zhang D, Yang XH, Li XF, Liu MH.
    Zhongguo Zhong Yao Za Zhi; 2021 Mar 04; 46(5):1197-1204. PubMed ID: 33787115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.